Literature DB >> 19581630

The in vivo expression of dipeptidyl peptidases 8 and 9.

Denise M T Yu1, Katerina Ajami, Margaret G Gall, Joohong Park, C Soon Lee, Kathryn A Evans, Eileen A McLaughlin, Melissa R Pitman, Catherine A Abbott, Geoffrey W McCaughan, Mark D Gorrell.   

Abstract

The dipeptidyl peptidase IV (DPIV) enzyme family contains both potential and proven therapeutic targets. Recent reports indicate the presence of DP8 and DP9 in peripheral blood lymphocytes, testis, lung, and brain. For a more comprehensive understanding of DP8 and DP9 tissue and cellular expression, mRNA and enzyme activity were examined. Many organs from C57BL/6 wild-type and DPIV gene-knockout mice were examined; DP8/9 enzyme activity was detected in the immune system, brain, testis, muscle, and epithelia. In situ hybridization localized DP8 and DP9 mRNA to lymphocytes and epithelial cells in liver, gastrointestinal tract, lymph node, spleen, and lung. DP8 and DP9 mRNA was detected in baboon and mouse testis, and DP9 expression was elevated in human testicular cancers. DP8 and DP9 mRNA were ubiquitous in day 17 mouse embryo, with greatest expression in epithelium (skin and gastrointestinal tract) and brain. Thus, DP8 and DP9 are widely expressed enzymes. Their expression in lymphocytes and epithelia indicates potential for roles in the digestive and immune systems. This manuscript contains online supplemental material at http://www.jhc.org. Please visit this article online to view these materials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581630      PMCID: PMC2762882          DOI: 10.1369/jhc.2009.953760

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  52 in total

1.  Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4.

Authors:  Nadine Frerker; Leona Wagner; Raik Wolf; Ulrich Heiser; Torsten Hoffmann; Jens-Ulrich Rahfeld; Jutta Schade; Tim Karl; Hassan Y Naim; Marwan Alfalah; Hans-Ulrich Demuth; Stephan von Hörsten
Journal:  Peptides       Date:  2007-01-16       Impact factor: 3.750

2.  Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

Authors:  D Marguet; L Baggio; T Kobayashi; A M Bernard; M Pierres; P F Nielsen; U Ribel; T Watanabe; D J Drucker; N Wagtmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26.

Authors:  Vera Preller; Annegret Gerber; Sabine Wrenger; Mauro Togni; Didier Marguet; Janine Tadje; Uwe Lendeckel; Christoph Röcken; Jürgen Faust; Klaus Neubert; Burkhart Schraven; Roland Martin; Siegfried Ansorge; Stefan Brocke; Dirk Reinhold
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

Review 4.  CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.

Authors:  M D Gorrell; V Gysbers; G W McCaughan
Journal:  Scand J Immunol       Date:  2001-09       Impact factor: 3.487

5.  Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis.

Authors:  Denise M T Yu; Xin M Wang; Geoffrey W McCaughan; Mark D Gorrell
Journal:  FEBS J       Date:  2006-06       Impact factor: 5.542

6.  Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8.

Authors:  C A Abbott; D M Yu; E Woollatt; G R Sutherland; G W McCaughan; M D Gorrell
Journal:  Eur J Biochem       Date:  2000-10

7.  Dipeptidyl peptidase 8/9-like activity in human leukocytes.

Authors:  Marie-Berthe Maes; Véronique Dubois; Inger Brandt; Anne-Marie Lambeir; Pieter Van der Veken; Koen Augustyns; Jonathan D Cheng; Xin Chen; Simon Scharpé; Ingrid De Meester
Journal:  J Leukoc Biol       Date:  2007-02-07       Impact factor: 4.962

8.  CXCR4/SDF1 interaction inhibits the primordial to primary follicle transition in the neonatal mouse ovary.

Authors:  Janet E Holt; Andrew Jackson; Shaun D Roman; R John Aitken; Peter Koopman; Eileen A McLaughlin
Journal:  Dev Biol       Date:  2006-03-20       Impact factor: 3.582

9.  Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade.

Authors:  Jarmila Stremenova; Evzen Krepela; Vladislav Mares; Julie Trim; Vladimir Dbaly; Josef Marek; Zdislava Vanickova; Vera Lisa; Chris Yea; Aleksi Sedo
Journal:  Int J Oncol       Date:  2007-10       Impact factor: 5.650

10.  Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV.

Authors:  Jais R Bjelke; Jesper Christensen; Per F Nielsen; Sven Branner; Anders B Kanstrup; Nicolai Wagtmann; Hanne B Rasmussen
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

View more
  23 in total

1.  The amino terminus extension in the long dipeptidyl peptidase 9 isoform contains a nuclear localization signal targeting the active peptidase to the nucleus.

Authors:  Daniela Justa-Schuch; Ulrike Möller; Ruth Geiss-Friedlander
Journal:  Cell Mol Life Sci       Date:  2014-02-23       Impact factor: 9.261

2.  Discoidin domain receptor 1: isoform expression and potential functions in cirrhotic human liver.

Authors:  Sunmi Song; Nicholas A Shackel; Xin M Wang; Katerina Ajami; Geoffrey W McCaughan; Mark D Gorrell
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

3.  Differential expression of dipeptidyl peptidase IV in human versus cynomolgus monkey skin eccrine sweat glands.

Authors:  Serafino Pantano; Valérie Dubost; Katy Darribat; Philippe Couttet; Olivier Grenet; Steven Busch; Pierre Moulin
Journal:  J Mol Histol       Date:  2013-07-24       Impact factor: 2.611

Review 4.  The expression of proline-specific enzymes in the human lung.

Authors:  Gwendolyn Vliegen; Tom K Raju; Dirk Adriaensen; Anne-Marie Lambeir; Ingrid De Meester
Journal:  Ann Transl Med       Date:  2017-03

5.  Circulating fibroblast activation protein and dipeptidyl peptidase 4 in rheumatoid arthritis and systemic sclerosis.

Authors:  Premarani Sinnathurai; Wendy Lau; Ana Julia Vieira de Ribeiro; William W Bachovchin; Helen Englert; Graydon Howe; David Spencer; Nicholas Manolios; Mark D Gorrell
Journal:  Int J Rheum Dis       Date:  2016-12-19       Impact factor: 2.454

6.  A novel SUMO1-specific interacting motif in dipeptidyl peptidase 9 (DPP9) that is important for enzymatic regulation.

Authors:  Esther Pilla; Ulrike Möller; Guido Sauer; Francesca Mattiroli; Frauke Melchior; Ruth Geiss-Friedlander
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

7.  Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.

Authors:  Sumaiya Chowdhury; Yiqian Chen; Tsun-Wen Yao; Katerina Ajami; Xin M Wang; Yury Popov; Detlef Schuppan; Patrick Bertolino; Geoffrey W McCaughan; Denise Mt Yu; Mark D Gorrell
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

8.  Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.

Authors:  Suncica Buljevic; Dijana Detel; Lara Baticic Pucar; Radovan Mihelic; Tomislav Madarevic; Branko Sestan; Jadranka Varljen
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

9.  Grassypeptolides as natural inhibitors of dipeptidyl peptidase 8 and T-cell activation.

Authors:  Jason C Kwan; Yanxia Liu; Ranjala Ratnayake; Ryo Hatano; Akiko Kuribara; Chiko Morimoto; Kei Ohnuma; Valerie J Paul; Tao Ye; Hendrik Luesch
Journal:  Chembiochem       Date:  2014-03-03       Impact factor: 3.164

Review 10.  Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins.

Authors:  L Wagner; C Klemann; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-03-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.